Pharmacological and Pharmacognostical benchmarks of Shirisha (Albizia lebbeck Benth.) in Ayurveda Nighantus
DOI:
https://doi.org/10.70066/jahm.v11i12.1180Keywords:
Albizia lebbeck Benth, Shirisha, Nighantu, AyurvedaAbstract
Shirisha is botanically known as Albizia lebbeck Benth., which has many therapeutic properties. Shirisha is an economically important plant for medicinal uses. In Ayurvedic literature, Shirisha is considered as Vishaghna Dravya which means an antidote against all type of poisons. There are so many therapeutic uses mentioned in different Ayurvedic texts. Since the Vedic period, Shirisha has been described in so many places with the name Shirisha and its various synonyms. Variation in descriptions of Shirisha are observed in different Nighantu. This review highlights the detail description about Shirisha given in Nighantu and also description of included Gana or Skandha from Brihattrayi.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 NIRALI VEKARIYA

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.